EYPT

#2338
EyePoint, Inc. Common Stock
14.3400 USD
-1.24%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
14.3400
14.3400
Yıllık Aralık
9.6500
19.0100
Günlük Değişim
-1.24%
Aylık Değişim
+6.86%
6 aylık değişim
+19.50%
Yıllık Değişim
+19.50%
Önceki Kapanış
14.5200
Open
14.3400
Bid
Ask
Low
14.3400
High
14.3400
Hacim
94
Open full chart

Financials

Overview Rapor Statistics
Quarterly Annual
  • Market Capitalization 1.1964 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.76
Price to sales ratio
0.04

EyePoint Inc

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Haberler